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January 2013292 AbstractsIncreased Risk For Adverse Events Following Re-Intervention In Pa-
tients With Restenosis After Prior CEA
Margriet Fokkema, MD,1 Gert Jan de Borst, MD PhD,2 Brian W. Nolan,
MD,3 Robert A. Cambria, MD,4 Richard J. Powell, MD,5 Andrew C.
Stanley, MD,6 Marc L. Schermerhorn, MD1. 1Beth Israel Deaconess Med-
ical Center, Boston, Mass; 2University Medical Center Utrecht, Utrecht,
Netherlands; 3Darthmouth-HitchcockMedical Center, Lebanon, NH; 4East-
ernMaineMedical Center, Bangor,Me; 5Dartmouth-HitchcockMedical Cen-
ter, Lebanon, NH; 6Fletcher Allen Health Care, Burlington, Vt
Objectives:Outcomes of patients undergoing reintervention for reste-
nosis after prior ipsilateral carotid endarterectomy (CEA) in the era of
carotid stenting (CAS) are unclear. We assessed perioperative results and
durability of CAS and CEA in symptomatic (SX) and asymptomatic (ASX)
patients undergoing reintervention.
Methods: Patients undergoing CAS and CEA were identified in the
Vascular Study Group of New England (VSGNE) between January 2003
and November 2011. Demographics, preoperative risk factors, 30-day out-
come (stroke/death), cranial nerve injury, and restenosis50% at follow-up
were compared across primary procedures and reinterventions (CAS vs
CEA). Fisher exact test or 2 test were used to analyze significance differ-
ences (P  .05) between the different groups.
Results: Of a total of 9357 CEA procedures (33% SX), 212 patients
(2.3%) underwent redoCEA (36% SX).Of 663CAS procedures (34% SX), 220
patients (33%) underwent CAS after prior ipsilateral CEA (31% SX). Demo-
graphics of patients undergoing CAS after prior CEA were comparable to
patients undergoing redo CEA. Forty percent of CAS patients had at least one
medical high-risk factor forCEA.Asymptomatic patients undergoing redoCEA
had a significantly higher stroke/death risk (3.0%) than primary CEA (0.9%),
but equivalent to CAS after prior CEA (2.0%; Table). No difference in periop-
erative cranial nerve injury was identified between redo CEA and primary CEA
(5.2% vs 4.7%). Follow-up was available for 56.7% of CAS (median, 254 days)
and 68% of CEA patients (median, 370 days). Redo CEA had higher rates of
50% restenosis than primary CEA (14.8% vs 9.8%, P  .06); there was no
significant difference between CAS after prior CEA (17.2%) compared with
redo CEA (14.8%, P .62) and primary CAS (18.6%, P .73).
Conclusions: In the VSGNE, CEA and CAS showed equivalent outcome
(30-day stroke/death risk and restenosis) in ASX and SX patients treated for
restenosis after prior ipsilateral CEA. However, regardless of procedure, the risk of
reintervention was increased compared with patients undergoing primary CEA.
Table. 30-day stroke/death risk for patients undergoing CEA or CAS







CAS 0.7% 2.0% 0.35 7.6% 4.4% .56
CEA 0.9% 3.0% 0.04 1.8% 4.0% .16
P-value 1.0 0.71 .01 1.0
ASX, Asymptomatic, SX, symptomatic.
Bold values indicate, P value .05.
Office-Based Endovascular Suite Is Safe for Most Procedures
Krishna M. Jain, MD, John Munn, MD, Mark Rummel, Dan Johnston,
Chris Longton. Advanced Vascular Surgery, Kalamazoo, Mich
Objective: This study assessed the safety of endovascular procedures in
office setting over a long-term period.
Methods: Between May 22, 2005, and November 22, 2011, 2309
patients underwent 5029 percutaneous procedures in an office-based proce-
dural suite. Demographics of the patients, complications, and hospital transfers
were documented in a prospective manner. Follow-up calls were made, and a
satisfaction survey was administered. Most procedures were done under local
anesthesia or conscious sedation. All patients, except those having catheter
removal, received acetaminophen and hydrocodone (5/500), diazepam (5 to
10 mg), and one dose of an oral antibiotic preprocedure and three doses
postprocedure. Patients requiring conscious sedation received fentanyl and
midazolam. Conscious sedation was used in patients having peripheral arterial
interventions. Blood urea nitrogen, creatinine, international normalized ratio,
and partial thromboplastin time were performed prior to peripheral arterio-
grams. Patients on dialysis (end-stage renal disease) had no laboratory work
done preoperatively. Patients considered high risk, thosewho could not tolerate
the procedure with mild to moderate conscious sedation, or those who were
morbidly obese were not candidates for office-based procedures.
Results: There were no procedure-related deaths. Procedures and com-
plications are listed in the Table. There were 45 total complications (0.9%), of
which 20 (0.4%) were site related, 14 (0.3%) were deep venous thrombosis after
a venous procedure, and 11 (0.2%) were other medical problems. Seventeen
E
Srocedures required subsequent hospital transfer. Of those patients surveyed,
9% indicated that they would come back to the office for needed procedures.
Conclusions: When appropriately screened, almost all peripheral in-
erventions can be done in the office with minimal complications. For
ialysis patients, outpatient intervention has a very low complication rate and
s the mainstay of treatment to keep the dialysis access patent. Venous
nsufficiency when managed in the office setting also has a low complication
ate. Office-based procedural settings should be the preferred site for per-
utaneous interventions for arterial, venous, and dialysis-related procedures.














422 6 5 1 2
rteriogram with
interventiona
325 7 6 1 5
istulogram 162 1 1 1
istulogram
interventionb





498 7 3 4 6
VLT 313 8 2 6
VLT & micro 427 9 2 7
icrophlebectomy 110 2 1 1








VC filter insertion 4 1 1 1
VC filter removal 29
Arteriogram interventions include angioplasty, coiling, stenting, atherectomy.
Fistulogram interventions include angioplasty, coiling, stenting.
obot-Assisted Vascular Surgery, 250 Cases
etr Stadler, Libor Dvoracek, MD, Petr Vitasek, MD, Pavel Matous, MD.
Na Homolce Hospital, Praha 5, Czech Republic
Objectives: The feasibility of laparoscopic aortic surgery has been ade-
uately demonstrated. Our clinical experience with robot-assisted aortoiliac
econstruction for occlusive diseases, aneurysms, endoleak II treatment and
ybrid procedures performed using the da Vinci system is described.
Methods: Between November 2005 and April 2012, we performed
50 robot-assisted vascular procedures. A total of 189 patients were pro-
pectively evaluated for occlusive diseases, 48 patients for abdominal aortic
neurysm, two for common iliac artery aneurysm, two for splenic artery
neurysm, one for internal mammary artery aneurysm, four for hybrid
rocedures, and four for endoleak II treatment after endovascular aneurysm
epair. The robotic system was applied to construct vascular anastomosis, for
hromboendarterectomy, for aortoiliac reconstruction with closure patch,
or dissection of the splenic artery, and for posterior peritoneal suture. A
ombination of conventional laparoscopic surgeries and robotic surgeries
ere routinely included. A modified, fully robotic approach without laparo-
copic surgery was used in the last 80 cases in our series.
Results: A total of 241 cases (96,4%) were successfully completed
obotically, one patient’s surgery was discontinued during laparoscopy due
o heavy aortic calcification. Conversion was necessary in eight patients
3.2%). The 30-day mortality rate was 0.4%, and nonlethal postoperative
omplications were observed in 13 patients (5.2%).
Conclusions: Our experience with robot-assisted laparoscopic surgery has
emonstrated the feasibility of this technique for occlusive diseases, aneurysms,
ndoleak II treatment after endovascular aneurysm repair, and hybrid procedures.
he da Vinci robotic system facilitated the creation of the aortic anastomosis and
hortened the aortic clamping time comparedwith purely laparoscopic techniques.
dentifying TAAA IV Patients at High Risk for Open Repair
apan S. Desai, MD, PhD,MBA, Kristofer Charlton-Ouw, MD, Harleen K.
andhu, MD, Charles C. Miller, III, PhD, Ali Azizzadeh, MD, Anthony L.
strera, MD, Hazim J. Safi, MD. University of Texas Houston Medical
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Volume 57, Number 1 Abstracts 293Objectives: Open surgical repair for thoracoabdominal aortic aneu-
rysm extent IV (TAAA IV) patients was thought to be low risk for morbidity
and mortality, especially when compared with more extensive disease found
in other variations (ie, extent II). The purpose of this report is to identify
patient comorbidities that adversely affect survival in open repair for TAAA
IV and to identify candidates suitable for alternative management.
Methods: We completed a retrospective analysis of a prospectively
collected institutional database of TAAA repairs completed between 1991
and 2010. During this period, our standard protocol for repair evolved to
include the spinal protective adjuncts of distal aortic perfusion, passive
moderate hypothermia, and perioperative cerebrospinal fluid drainage. Uni-
variate andmultivariate analysis were used to determine the effect of adjuncts
and patient comorbidities on perioperative neurologic deficits and death.
Results: We repaired 1528 TAAA during the study period, including
241 TAAA IV (67%male; mean age, 70 years). Three of 241 patients (1.2%)
suffered neurologic deficits such as paraplegia or paraparesis. In 91 of 241
patients, spinal protective adjuncts were not used and did not significantly
affect the rate of neurologic deficits. Overall mortality in patients with
preserved preoperative renal function (glomerular filtration rate [GFR]60
mL/min/1.73m2) was 10 of 241 (8.3%). However, the 60 patients in the
lowest quartile of renal function (GFR 44 mL/min/1.73m2) had a
mortality of 38.3% (odds ratio [OR], 6.96; 95% confidence interval [CI],
2.43-19.95, P  .0001).
Conclusions: Poor preoperative renal function is a statistically signifi-
cant factor that dramatically influences mortality after open TAAA IV repair.
Unlike open repair of other TAAA extents, spinal protective adjuncts did not
affect the rate of neurologic deficits. TAAA IV patients with poor renal




(%) OR 95% CI P
GFR 43 60 (24.9) 23 (38.3) 6.96 2.43-19.95 .0001
GFR 44-60 60 (24.9) 7 (11.7) 1.48 0.44-4.95 .74
GFR 61-81 60 (24.9) 5 (8.3) 1.02 0.22-4.69 .98
GFR 82 61 (25.3) 5 (8.2) 1
Intramural Hematoma of the Descending Aorta: Differences and Sim-
ilarities With Acute B Dissection
Jip L. Tolenaar,1 Kevin M. Harris,2 Gilbert R. Upchurch, Jr,3 Vincenzo
Rampoldi,1 Arturo Evangelista,4 Frans L. Moll,5 James B. Froehlich,6
Marco di Eusanio,7 Kim Eagle,6 Santi Trimarchi.1. 1Policlinico San Donato
IRCCS, Milan, Italy; 2Minneapolis, Minneapolis, Minn; 3University of
Virginia, Charlottesville, Va; 4Universitari Vall d’Hebron, Barcelona, Spain;
5University of Utrecht, Utrecht, Netherlands; 6University ofMichigan, Ann
Arbor, Mich; 7University of Bologna, Bologna, Italy
Objectives: Aortic intramural hematoma type B (IMHB) is a relatively
rare acute aortic syndrome that presents with symptoms similar to type B
aortic dissection (ABAD). Although the natural history of IMHB seems
associated with a less malignant course and better results after medical
treatment, such observation is not still totally explored. The purpose of this
study was to better characterize IMHB, comparing its clinical characteristics
and in-hospital and long-term outcome with patients presenting with classic
ABAD.
Methods:We analyzed 107 IMHB and 790 ABAD patients enrolled in
the International Registry of Acute Aortic Dissection (IRAD) between 1996
and 2012. We investigated the differences in presentation, diagnostic,
therapy, and outcome between these two cohorts.
Results: IMH patients presented at an older age (69.0 vs 62.6 years;
P  .001) and predominantly in males (61.7%). These patients presented
more frequently with chest pain (80.0% vs 68.9%; P  .020) and periaortic
hematoma (22.1% vs 13.2%; P  .020). IMHB patients were more often
treated medically (87.9%) than ABAD patients (62.2%; P  .001), while
endovascular or open surgical management, usually reserved for complicated
patients, were more adopted in ABAD (respectively, endovascular, 22.9% vs
6.5%; P .001; open surgical, 14.2% vs 4.7%; P .005) Overall in-hospital
mortality was 10.1% (89 patients; IMHB 6.5% vs ABAD 10.6%; P .118) of
which six IMHB died during medical treatment, two due to aortic rupture.
During follow-up, mortality in IMHB patients was 8.9% and no adverse
events were observed.
Conclusions: Intramural hematoma of the descending aorta is a seri-
ous but rare disease with a relative stable although unpredictable course. Our
study confirms that its course is slightly more favorable than classic ABAD in
the acute setting. In the absence of suitable predictors for high-risk patients,
a complication-specific approach should be adopted. Medical treatment
combined with adequate follow-up should be administered in all patients,









ge (mean  SD) 69.0  12.3 62.6  14.1 .001
ender - male 66 (61.7%) 528 (66.8%) .290
ace - non-white 10 (9.6%) 127 (16.9%) .058
ymptoms
hest pain 84 (80.0%) 527 (68.9%) .020
ack pain 84 (78.5%) 527 (69.8%) .064
bdominal pain 36 (35.0%) 325 (43.6%) .097
adiating pain 36 (35.3%) 332 (44.9%) .068
brupt onset of pain 84 (81.6%) 653 (87.4%) .100
omplications
eriartic hematoma 23 (22.1%) 104 (13.2%) .020
hock 0 (0%) 9 (1.2%0 .259
esenteric ischemia/infarction 0 (0%) 49 (6.6%) .008
pinal cord ischemia 0 (0%) 12 (1.7%) .201
cute renal failure 9 (9.0%) 115 (15.5%) .086
imb ischemia 0 (0%) 75 (10.1)% .001
anagement
edical management 94 (87.9%) 491 (62.2%) .001
ndovascular management 7 (6.5%) 181 (22.9%) .001
urgical management 5 (4.7%) 112 (14.2%) .005
ybrid management 1 (0.9%) 6 (0.8%) .590
utcome
n-hospital mortality 7 (6.5%) 84 (10.6%) .188
ortality after 1 year 4 (8.9%) 19 (6.9%) .547
utcomes of Open and Endovascular Repair for Ruptured and Non-
uptured Internal Iliac Artery Aneurysms
uhammad A. Rana, MD, Manju Kalra, MD, Gustavo S. Oderich, MD,
eter Gloviczki, MD, Audra Duncan, MD,Mark D. Fleming, MD, Thomas
. Bower, MD. Mayo Clinic, Rochester, Minn
Objectives: This study evaluated outcomes of open and endovascular
epair (EVAR) of internal iliac artery (ILA) aneurysms (IIAAs) with or
ithout preservation of IIA flow.
Methods:We reviewed the clinical data of consecutive patients treated
or IIAAs between 2001 and 2012. End points were morbidity, mortality,
raft patency, and freedom from pelvic ischemic symptoms (hip claudica-
ion, ischemic colitis, and spinal cord injury).
Results: There were 64 patients (57 men, 7 women) with mean age
f 73 years (range, 52-90 years). Seventy-eight IIAAs (36 unilateral and
8 bilateral) were treated. Fifty-five patients (86%) had elective repair (mean
ize, 3.0 1.2 cm) and nine (14%) required emergent repair (mean size, 6.7
2.4; range, 3.6-10 cm). Open repair in 48 patients (75%; 43 elective, 5
mergent) included IIA bypass in 38 or endoaneurysmorrhaphy in 10,
ombined with aortoiliac reconstruction in 40. EVAR in 16 patients (25%;
2 elective, 4 emergent) required IIA coil embolization in 11, iliac branch
evice in three, or IIA bypass in two, combined with bifurcated aortic stent
rafts in eight. Early mortality was 1.8% for elective (1 of 43 open, 0 of 12
ndovascular) and 11% for emergent repair (1 of 5 open, 0 of 4 endovascular;
 NS). Early morbidity and length of stay were significantly (P  .05)
igher for open repair (39%, mean 9.7  4.3 days) than for EVAR (12%;
ean 4  4.8 days). Pelvic ischemic complications occurred in 11 patients
17%), including hip claudication in eight, ischemic colitis in two, paraplegia
n one. Pelvic ischemic complications occurred in 11 patients (25%) who had
xclusion of at least one IIA, and in none of the patients with bilateral IIA
reservation (P  .03). There was no difference in pelvic ischemic compli-
ations for elective (16%) vs emergent repair (22%) nor for open repair (13%)
s EVAR (24%). After a mean follow-up of 2.4 years, primary and secondary
atency rates of IIAA bypasses were 95%. Freedom from pelvic ischemic
omplications at 2 years was 100% for patients with two patent IIAs and 75%
8% for those who had at least one IIA excluded (P  .05).
Conclusions: Endovascular repair of IIAAs is associated with fewer
omplications and shorter hospital stay than with open repair. Patency of IIA
ypasses is excellent. Patients who had preservation of IIA flow with bypass
r iliac branch device developed no pelvic ischemic symptoms.
unctional Outcome and Mortality After Open and Endovascular
econdary Intervention for Thoracic Endovascular Aortic Repair
hayree Butler, MD, Salvatore T. Scali, MD, AdamW. Beck, MD, Robert J.
eezor, MD, Peter R. Nelson, MD, MPH, Scott A. Berceli, MD, PhD,
homas S. Huber, MD, PhD, Catherine K. Chang, MD. University of
lorida-Gainesville, Gainesville, FlaObjectives: Results of thoracic endovascular aortic repair (TEVAR)
ave demonstrated improved morbidity and short-term mortality compared
